Fieldpoint Private Securities’s Precigen PGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-700
Closed -$13K 525
2017
Q3
$13K Buy
+700
New +$14.4K 0.01% 569
2017
Q2
Sell
-700
Closed -$14K 291
2017
Q1
$14K Buy
+700
New +$15.6K 0.01% 293

Other funds holding PGEN

Fieldpoint Private Securities's PGEN Position: Q4 2017 in Review

Fieldpoint Private Securities sold out of Precigen (PGEN) in Q4 2017, closing a stake of 700 shares — an estimated $13K sold.

Fieldpoint Private Securities first reported a position in PGEN in Q1 2017 and held it in 2 quarters. The position peaked at $14K in Q1 2017. 162 funds tracked by Wall St. Rank hold PGEN as of Q4 2017.

  • Fieldpoint Private Securities reported no remaining Precigen position as of Q4 2017 after selling out during the quarter.
  • Fieldpoint Private Securities sold 700 Precigen shares in Q4 2017, an estimated $13K.
  • Fieldpoint Private Securities first reported a position in Precigen in Q1 2017 and held it in 2 quarters.
  • Fieldpoint Private Securities's Precigen position peaked at $14K in Q1 2017.
  • 162 funds tracked by Wall St. Rank held Precigen as of Q4 2017.

Based on Fieldpoint Private Securities's 13F filing for Q4 2017, filed 15 Feb 2018.